Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Genomic landscape of treatment refractory metastatic colorectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Management of late adverse effects after chemoradiation for anal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Introduction: Prediction models using logistic regression may perform poorly in external patient cohorts. However, there is a need to standardize and validate models for clinical use. The purpose of this project was to describe a method for validation of external NTCP models used for patient selection in the randomized trial of protons versus photons in head and neck cancer radiotherapy, DAHANCA 35. Material and methods: Organs at risk of 588 patients treated primarily with IMRT in the randomized controlled DAHANCA19 trial were retrospectively contoured according to recent international recommendations. Dose metrics were extracted using MatLab and all clinical parameters were retrieved from the DAHANCA database. The model proposed by Christianen et al. to predict physician-rated dysphagia was validated through the closed testing, where change of the model intercept, slope and individual beta's were tested for significant prediction improvements. Results: Six months prevalence of dysphagia in the validation cohort was 33%. The closed testing procedure for physician-rated dysphagia showed that the Christianen et al. model needed an intercept refitting for the best match for the Danish patients. The intercept update increased the risk of dysphagia for the validation cohort by 7.9 ± 2.5% point. For the raw model performance, the Brier score (mean squared residual) was 0.467, which improved significantly with a new intercept to 0.415. Conclusions: The previously published Dutch dysphagia model needed an intercept update to match the Danish patient cohort. The implementation of a closed testing procedure on the current validation cohort allows quick and efficient validation of external NTCP models for patient selection in the future.

OriginalsprogEngelsk
TidsskriftActa oncologica
Vol/bind58
Udgave nummer10
Sider (fra-til)1410-1415
Antal sider6
ISSN0284-186X
DOI
StatusUdgivet - 3 okt. 2019

ID: 58596458